KIMERA-VASC™ (Two-Component Vascular Research Platform)
KIMERA-VASC™ is a modular two-component research platform engineered for vascular studies. The system pairs a cyclodextrin derivative (Sulfobutylether β-cyclodextrin) with a selectable peptide, providing a flexible framework for modeling complex biological conditions in an in vitro environment. By allowing researchers to modulate lipid environments while simultaneously introducing specific signaling cues, this platform enables highly controlled experimental design for investigating vascular cell responses and signaling interactions.
Additional Properties
| Property | Specification |
|---|---|
| System Components | Sulfobutylether β-cyclodextrin (SBE-β-CD) + Selectable Peptide |
| Platform Class | Modular in vitro vascular research system |
| Appearance | Lyophilized powder |
Research Applications
The KIMERA-VASC™ platform facilitates the creation of integrated models to study vascular biology and cellular signaling.
Primary fields of in vitro laboratory investigation include:
-
Lipid Stress Modeling: Utilizing SBE-β-CD to systematically alter membrane cholesterol content in cell cultures.
-
Signaling Pathway Interaction: Observing how peptide-based signaling cues function within a modified lipid environment.
-
Comparative Signaling Studies: Modulating the peptide component to assess different biological contexts or competitive signaling interactions.
-
Vascular Cell Assays: Application in endothelial or smooth muscle cell models.
-
Mechanistic Adaptation Research: Studying cellular responses to combined environmental and signaling modifications.
Storage & Handling Guidelines
Store at controlled room temperature, sealed and protected from light.
Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.
Related Research Compounds
Research Use Disclaimer
Research Use Only Disclaimer: This product is labeled and sold “For Research Use Only — NOT FOR HUMAN CONSUMPTION.” It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.
